Article Text

Download PDFPDF
Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study
  1. M Wright1,
  2. R Goldin1,
  3. A Fabre1,
  4. J Lloyd1,
  5. H Thomas1,
  6. C Trepo2,
  7. P Pradat2,
  8. M Thursz1,
  9. On Behalf Of The Hencore Collaboration
  1. 1Hepatology Section, Faculty of Medicine, Imperial College, London W2 1NY, UK
  2. 2Department of Gastroenterology, Hotel-Dieu, 1 Place de l’Hopital, F-69288 Lyon, Cedex 02, France
  1. Correspondence to:
    Dr M Wright, Department of Medicine, Imperial College of Science, Technology, and Medicine, St Mary’s Hospital (QEQM Wing), South Wharf Road, London W2 1NY, UK;
    mark.wright{at}ic.ac.uk

Abstract

Introduction: The rate of development of liver fibrosis in hepatitis C virus (HCV) infection varies between individuals. This accounts for the variation in duration of progression to cirrhosis. The aims of this study were: (1) to determine whether fibrosis progresses linearly through the grading scales and (2) to identify factors which influence the rate of fibrosis.

Methods: HCV infected patients who had undergone at least one liver biopsy were identified. Biopsies were scored using the modified HAI (Ishak) and METAVIR systems, which were compared. Patients were treatment naïve at first biopsy. Demographic features were examined for their relationship to fibrosis rate (defined as fibrosis stage/infection duration) using univariate and multivariate analysis. A subgroup of patients with two biopsies was examined to test the assumption that fibrosis progresses in a linear fashion.

Results: A total of 917 patients were included. Male sex (p<0.00001), older age at infection (p⩽0.00001), and viral genotype non-1 (p=0.005) were all associated with a rapid rate of fibrosis. On multiple linear regression they accounted for 29.5% of the variability in fibrosis rate (r2=0.295). METAVIR and Ishak scores were highly correlated (r=0.935, p<0.0001). In 137 patients who had two biopsies, the predicted probability for an increase of 1 on the fibrosis score was too low to assess linearity.

Conclusions: Demographic features account for a minority of fibrosis rate variability. The Ishak and METAVIR scoring systems are equivalent. Linearity of fibrosis progression cannot be assessed in biopsies only a few years apart.

  • hepatitis C
  • biopsy
  • fibrosis
  • natural history
  • HCV, hepatitis C virus

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

Linked Articles

  • Ian Forgacs